Close Menu

NEW YORK (GenomeWeb News) – Biotechnology company Antigen Discovery said today it has received a three-year, $2.5 million award from the National Institutes of Health to use its proteome microarray technology to develop companion diagnostics for Sanaria's malaria products in human trials.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.